Remote case management to prevent suicide after psychiatric hospital discharge
SAFEGUARD Phase 2 Pathfinding Study
This project will test whether a 6-month remote program called Pathfinding helps active-duty Army soldiers reduce suicidal behavior after leaving inpatient psychiatric care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Uniformed Services University of the Health Sciences Federal |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT07404787 on ClinicalTrials.gov |
What this trial studies
Active-duty Regular Army soldiers discharged from inpatient psychiatric care at military treatment facilities across the U.S. will be identified and invited to participate. Consenting participants will be randomized to receive usual post-discharge care (TAU) or TAU plus Pathfinding, a six-month telehealth case management intervention delivered by centrally trained masters-level mental health professionals. Participants complete a baseline assessment and follow-up assessments at 6 and 12 months, with additional review of electronic health records and Army administrative data. The intervention adapts elements of CLASP and CTI for a military population to provide scalable, remote support during the high-risk post-discharge period.
Who should consider this trial
Good fit: Active-duty Regular Army soldiers recently discharged from inpatient psychiatric care at a U.S. military treatment facility who can use a telephone or computer and can provide informed consent are the intended participants.
Not a fit: Those with impaired ability to consent, a terminal illness, a positive screen for post-discharge suicide-related behaviors, or who cannot complete the baseline survey within 30 days of discharge are excluded and unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, Pathfinding could reduce post-discharge suicidal behaviors and improve continuity of care for soldiers returning to the community.
How similar studies have performed: Elements from CLASP and CTI have previously reduced post-discharge suicidal behavior, but combining them into a remotely delivered program for active-duty soldiers is a novel adaptation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Active duty Regular Army soldiers recently discharged from inpatient psychiatric care at a military treatment facility in the US * Access to telephone and computer (including smartphone) Exclusion Criteria: * Impaired ability to provide informed consent * Terminal illness * Failure to complete baseline survey within 30 days of discharge * Positive screen for post-discharge suicide-related behaviors
Where this trial is running
Bethesda, Maryland
- Uniformed Services University of the Health Sciences — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Study coordinator: Pathfinding Study
- Email: pathfinding-study@usuhs.edu
- Phone: 301-295-3409
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.